Research is an essential element of Pelican’s model for improving cancer surgery.
The Pelican Research Centre develops and manages research that will help to influence the way we treat pelvic and liver cancers in the near future. Our focus is on clinical trials – those that involve people – as they bring the latest treatments and approaches to today’s cancer patients.
We sponsor research that is relevant to the staging and treatment of bowel, liver or urological cancers and related diseases. We look for excellence, timeliness and originality of science, preferring research that includes the multi-disciplinary perspective and takes account of Department of Health and NHS priorities and needs.
Pelican has invested over £2 million to date in innovative research. Pelican is a member of the Association of Medical Research Charities (AMRC) and a partner organisation of the National Institute of Health Research.
Research programmes that we are currently supporting include:
MERCURY RESEARCH PROGRAMME:
• MERCURY II (Basingstoke and Royal Marsden Hospital)
• Radiological and Pathological evaluation of Poor Prognosis Rectal Cancer (Royal Marsden and Southampton feasibility study 2012)
• Deferral of Surgery (Royal Marsden)
Liver Quality of Life Study (Basingstoke)
Prostate HIFU Focal Therapy Studies (University College Hospital in London)
Prostate MRI before biopsy feasibility Study (University College London Hospital)
Complement Cascade Predictors for Laparoscopic and Open Colorectal Surgery (Royal Devon and Exeter Hospital)
Pelican is interested in hearing proposals covering our areas of interest.
- Research strategy
- Bowel cancer research
- Liver cancer research
- Prostate cancer research
- Bladder cancer research
- Clinical trials
- Info for researchers
- Surgical videos